Japan · Delayed Price · Currency is JPY BML, Inc. Company Description
BML, Inc. provides contract clinical testing and related services in Japan.
The company offers a range of laboratory testing, such as biochemical and hematologic examination; laboratory test, including tumor markers, infectious diseases, hormones, cellular immunity, genetics, bacteriological tests, and other test; specialized testing in oncology, infectious diseases, diabetes, hypertension, allergies, genetics, and more areas, as well as develops Frontier and Symphony automation systems, which automate pre-testing from specimen sorting to dispensing.
It also provides contract clinical testing, including endocrine, plasma protein, biochemical, viral, immunoserological, hematological, cellular immunity, bacteriological, and histopathological, pathological, and cytological tests; specimen receiving service; and medical information system services, which include electronic medical charts for clinics without beds.
In addition, the company is involved in manufacturing and supply services for medical equipment and supplies; real estate leasing and insurance agency business; providing food hygiene inspection and food consulting services; and dispensing pharmacy services.
The company was incorporated in 1955 and is headquartered in Tokyo, Japan.
| Country | Japan |
| Founded | 1955 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 4,558 |
| CEO | Kensuke Kondo |
Contact Details
Address: 5-21-3 Sendagaya Tokyo, 151-0051 Japan | |
| Phone | 81 3 3350 0111 |
| Website | bml.co.jp |
Stock Details
| Ticker Symbol | 4694 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3799700004 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Kensuke Kondo | Chief Executive Officer |